Evidence map›Paper›PMID 39790464›Full record

ArticleNeuroethics2024

"In the spectrum of people who are healthy": Views of individuals at risk of dementia on using neurotechnology for cognitive enhancement.

Asad Beck, Andreas Schönau, Kate MacDuffie, Ishan Dasgupta, Garrett Flynn, Dong Song, Sara Goering, Eran Klein

Abstract read
In one paragraph

Article in Neuroethics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Asad BeckDepartment of Biology, University of Washington, Life Sciences Building, Seattle, WA, 98195, USA.ORCID 0000-0002-8491-0567
Andreas SchönauDepartment of Philosophy, Savery Hall, University of Washington, Seattle, WA, 98195, USA.ORCID 0000-0003-2202-6351
Kate MacDuffieTreuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, 1900 Ninth Ave. Seattle, WA, 98101, USA.ORCID 0000-0003-1252-4373
Ishan DasguptaThe Dana Foundation, 1270 Avenue of the Americas, 12th Floor, New York, NY, 10020, USA.ORCID 0000-0002-5748-1840
Garrett FlynnDepartment of Biomedical Engineering, Denney Research Center, University of Southern California, Los Angeles, CA, 90089-1111, USA.ORCID 0000-0002-7996-8713
Dong SongDepartment of Biomedical Engineering, Denney Research Center, University of Southern California, Los Angeles, CA, 90089-1111, USA.ORCID 0000-0002-6179-1120
Sara GoeringDepartment of Philosophy, Savery Hall, University of Washington, Seattle, WA, 98195, USA.ORCID 0000-0002-1882-3764
Eran KleinDepartment of Philosophy, Savery Hall, University of Washington, Seattle, WA, 98195, USA.ORCID 0000-0002-0132-5777

Funding

Research Education ComponentP30AG066518 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KEVIN M DUFF, Lisa C Silbert · 2020 to 2026
$28.6M
Outreach, Recruitment and Education CoreP30AG008017 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI WOLTJER, RANDALL L · 1990 to 2019
$27.7M
Post-trial obligations in neurotechnologyRF1MH117800 · NIMH · UNIVERSITY OF WASHINGTON · PI GOERING, SARA, KLEIN, ERAN · 2018 to 2020
$2.2M
Sleep in fear-entrained miceR01NS110012 · NINDS · UNIVERSITY OF WASHINGTON · PI DE LA IGLESIA, HORACIO O, KIM, JEANSOK JOHN · 2019 to 2023
$1.8M
NIA NIH HHS P30 AG008017NIA NIH HHS P30 AG066518NIMH NIH HHS RF1 MH117800NINDS NIH HHS R01 NS110012
6 · The paper itself

Abstract

Neurotechnological cognitive enhancement has become an area of intense scientific, policy, and ethical interest. However, while work has increasingly focused on ethical views of the general public, less studied are those with personal connections to cognitive impairment. Using a mixed-methods design, we surveyed attitudes regarding implantable neurotechnological cognitive enhancement in individuals who self-identified as having increased likelihood of developing dementia (n=25; 'Our Study'), compared to a nationally representative sample of Americans (n=4726; 'Pew Study'). Participants in Our Study were additionally shown four videos showcasing hypothetical neurotechnological devices designed to enhance different cognitive abilities and were interviewed for more in-depth responses. Both groups expressed comparable degrees of worry and acknowledgement of potential ethical ramifications (all

Indexed as

cognitive enhancementDeep brain stimulationdementiaqualitative researchsurvey

Identifiers

PMID39790464
PMCPMC11709137

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.